<DOC>
	<DOC>NCT01204320</DOC>
	<brief_summary>This is a multicentric randomized comparison between paclitaxel-coated balloon angioplasty or paclitaxel-eluting stent implantation in patients with stable or unstable angina with the evaluation of restenosis by Quantitative Coronary Analysis.</brief_summary>
	<brief_title>A COMparison Between PAClitaxel-coated Balloon and pacliTaxel-eluting Stent in the Treatment of In-Stent Restenosis (COMPACT-ISR)</brief_title>
	<detailed_description>The purpose of this study is to determine the late luminal loss by Quantitative Coronary Analysis at 6 month-follow up after paclitaxel-coated balloon angioplasty or paclitaxel-eluting stent implantation in the treatment of in-stent restenosis.</detailed_description>
	<mesh_term>Angina Pectoris</mesh_term>
	<mesh_term>Angina, Unstable</mesh_term>
	<mesh_term>Angina, Stable</mesh_term>
	<mesh_term>Paclitaxel</mesh_term>
	<mesh_term>Albumin-Bound Paclitaxel</mesh_term>
	<criteria>informed consent &gt;18y Stable Angina or Unstable Angina Single restenotic lesion in a previously stented coronary artery Acute Myocardial Infarction within 72h Serum Creatinine&gt;2.0 mg/dL Contraindications to ASA, Heparin, Clopidogrel, Ticlopidine, Abciximab, Tirofiban, Paclitaxel Contraindications to contrast media Life expectancy &lt; 2y Target Lesion length &gt; 30mm Target Lesion diameter &lt;= 2.5 mm Target stenosis &lt; 70% Massive Calcifications in the target segment Evidence of intracoronary thrombus</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2009</verification_date>
	<keyword>Restenosis</keyword>
	<keyword>POBA</keyword>
	<keyword>Stenting</keyword>
	<keyword>Paclitaxel</keyword>
</DOC>